Literature DB >> 3767976

Growth stimulating activity on 3T3 fibroblasts of the molecular weight 6,500-peptide purified from rat pancreatic juice.

S Fukuoka, T Fushiki, Y Kitagawa, E Sugimoto, K Iwai.   

Abstract

Growth stimulating activity of the molecular weight 6,500-peptide purified from rat pancreatic juice was measured on 3T3 fibroblasts. This peptide was reported to be a cholecystokinin-releasing peptide and to stimulate pancreatic enzyme secretion in the rat small intestine in response to food intake. Incorporation of [3H]thymidine and [35S]methionine into 3T3 was significantly stimulated and the cell number was also increased after 24-48 hr incubation with 10-100 ng/ml of the peptide. The increase in [3H]thymidine incorporation was dose-related and started 12 hr after the incubation, a peak being reached 24 hr after the incubation. These results show that this peptide exhibits growth stimulating activity to the mammalian cells, and suggest that the peptide might have a physiological effect in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767976     DOI: 10.1016/s0006-291x(86)80025-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.

Authors:  K H Herzig; I Schön; K Tatemoto; Y Ohe; Y Li; U R Fölsch; C Owyang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

2.  Complementary nucleotide sequence for monitor peptide, a novel cholecystokinin-releasing peptide in the rat.

Authors:  S I Fukuoka; G Scheele
Journal:  Nucleic Acids Res       Date:  1989-12-11       Impact factor: 16.971

3.  Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. Evaluation of its biological function as a growth factor.

Authors:  Y Ohmachi; A Murata; N Matsuura; T Yasuda; K Uda; T Mori
Journal:  Int J Pancreatol       Date:  1994-02

4.  Changes in plasma and duodenal cholecystokinin concentrations after pancreatic duct occlusion in rats.

Authors:  K Miyasaka; A Funakoshi; A Jimi; R Nakamura; M Matsumoto; K Kitani
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

5.  Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer.

Authors:  M Higashiyama; T Monden; N Tomita; M Murotani; Y Kawasaki; H Morimoto; A Murata; T Shimano; M Ogawa; T Mori
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

6.  Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor.

Authors:  T Niinobu; M Ogawa; A Murata; J Nishijima; T Mori
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.